Please assess the completion status of the following clinical trial:

Trial Title: Procalcitonin Antibiotic Consensus Trial (ProACT)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 18 years old~* A primary clinical diagnosis in the ED of acute LRTI (\< 28 days duration)~* Clinician willing to consider procalcitonin in antibiotic decision-making~Exclusion Criteria:~* Systemic antibiotics before ED presentation (All prophylactic antibiotic regimens, OR received \>1 dose within 72 hours prior to ED presentation)~* Current vasopressor use~* Mechanical ventilation (via endotracheal tube)~* Known severe immunosuppression~* Accompanying non-respiratory infections~* Known lung abscess or empyema~* Chronic dialysis~* Metastatic cancer~* Surgery in the past 7 days (excluding minor surgery such as skin biopsy)~* Incarcerated or homeless~* Enrolled in ProACT in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Procalcitonin (PCT) group (Type: EXPERIMENTAL): Procalcitonin (PCT) level; Results of procalcitonin level to treating clinician; Provide procalcitonin guideline to treating clinician; Telephone Visit at Day 15 and Day 30
- Usual Care group (Type: ACTIVE_COMPARATOR): Telephone Visit at Day 15 and Day 30

Based on this trial design, predict the completion outcome and termination type (if applicable).